Assessing the feasibility of high-Z metal (oxide) nanoparticles as contrast enhancement agents in proton imaging for a small animal irradiation platform by Liubchenko, Grigory et al.
Abstract of a presentation at the 51st annual conference of the Deutschen 
Gesellschaft für Medizinische Physik, 09.-11. September 2020, Virtual 
Conference. Published in: Ulrich Wolf and Bernhard Sattler (eds.), 
51.Jahrestagung Deutsche Gesellschaft für Medizinische Physik - Abstractband. 
Deutsche Gesellschaft für Medizinische Physik, Stuttgart. ISBN 978-3- 948023-10-
2 
 
Assessing the feasibility of high-Z metal (oxide) nanoparticles as contrast enhancement 
agents in proton imaging for a small animal irradiation platform 
 
Authors: G. Liubchenko (1), M. Würl (1), K. Schnürle (1), S. Meyer (1)*, J. Bortfeldt (1), C. 
Granja (2), C. Oancea (2), E. Verroi (3), F. Tommasino (3,4), K. Vallis (5), K. Parodi (1) 
 
Affiliations: 
(1) Faculty of Physics, Department of Medical Physics, Ludwig-Maximilians-Universität München, 
85748 Garching b. München, Germany 
(2) ADVACAM, Prague, Czech Republic 
(3) Trento Institute for Fundamental Physics and Applications (TIFPA), National Institute for 
Nuclear Physics, (INFN), Povo, Italy 
(4) Department of Physics, University of Trento, Povo, Italy 
(5) Oxford Institute for Radiation Oncology, Old Road Campus Research Building, Roosevelt 
Drive, OX3 7DQ, Oxford, United Kingdom 
*Current address: University of Pennsylvania, Department of Radiology, 3400 Spruce Street, One 
Silverstein, 19104, Philadelphia, PA, United States 
 
Introduction 
With increasing number of proton therapy facilities, proton imaging is becoming more relevant. It 
allows to directly reconstruct the relative (to water) stopping power (RSP), reducing range 
uncertainties in treatment planning. Tumour visualization can be improved by contrast 
enhancement, however little research is available about contrast agents for proton imaging. Our 
study assesses the feasibility of high-Z metal-(oxide) nanoparticles as contrast agents for proton 
imaging. 
Materials & Methods 
A FLUKA Monte Carlo simulation framework of a pre-clinical proton computed tomography (pCT) 
system [1] was used to evaluate the potential of contrast enhancement by gold, gadolinium(III)- and 
bismuth(III)-oxide nanoparticles. A cylindrical water phantom containing inserts (4mm diameter) 
with varying concentrations of homogeneously distributed metal-(oxide), mimicking the 
nanoparticles, was considered for imaging. To complement simulations, proton radiographies were 
taken at a clinical proton therapy facility using a miniaturized Timepix detector behind a 2cm thick 
PMMA block with insert (1cm diameter), filled with oil-gadolinium(III)-oxide nanoparticles 
solutions of varying concentrations. 
Results 
In simulated pCT images, notable contrast enhancement was observed at 4%wt for all three 
nanoparticles, with contrast-to-noise ratios between 2.2 and 2.7 (figure 1). Water equivalent 
thickness (WET) profiles of experimental radiographies (figure 2) indicate that contrast 




The feasibility of using gadolinium(III)-, bismuth(III)-oxide and gold nanoparticles as contrast 
agents in proton imaging has been tested in simulation and experimental (gadolinium only) studies. 
With already an appreciable contrast enhancement at 4%wt, these nanoparticles may provide a 




Figure 1: Reconstructed pCT image with various nanoparticle inserts. 
 
Figure 2: Experimental proton radiography WET profiles. The inset illustrates the block phantom, 
where the red line indicates profile’s position. 
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